News – Page 134 – Endpoints News

FDA warns Chinese drugmaker for serious GMP record violations

10 months ago

SOTIO, Biocytogen to jointly develop antibodies; Pliant's mid-stage liver disease data

10 months ago

Q&A: Jefferies analyst Brian Tanquilut talks Walgreens’ retreat from primary care and what’s sinking retailers’ ...

10 months ago

A teenager faced constant seizures. Could a drug developed just for him stop them?

10 months ago

Scorpion raises $150M with sights on the next wave of targeted therapies

10 months ago

Sionna licenses clinical-stage cystic fibrosis assets from AbbVie shortly after large Series C

10 months ago

Bain-backed Cardurion raises $260M to fund ex-Imara drug, buy more cardio assets

10 months ago

After last year's ImmunoGen pact, Vertex finds another conditioning agent partner in Orum

10 months ago

German biotech CatalYm raises $150M to repurpose obesity target for cancer

10 months ago

Vertex takes federal government to court over Casgevy fertility treatment program

10 months ago

Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau

10 months ago

CordenPharma injects €900M to boost GLP-1 manufacturing in US and Europe

10 months ago

Exclusive: Kins raises $7M to expand in-home and virtual physical therapy

10 months ago

Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year

10 months ago

Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab

10 months ago

J&J calls proposed class action talc suit 'meritless' as settlement vote deadline nears

10 months ago

EMA warns patients to tell doctors about GLP-1 usage before surgery

10 months ago

Revolution Medicines' RAS inhibitor shows promise in early-stage pancreatic cancer trial

10 months ago

Evofem inks women’s health deal; AusperBio brings in $37M

10 months ago

Updated: Lexeo Therapeutics' gene therapy shows potential for Friedreich's ataxia cardiomyopathy with early data

10 months ago

Artiva aims for $116M in second attempt at IPO to boost NK cell therapy pipeline

10 months ago

GSK HQ officially returns to central London after decades in city’s suburbs

10 months ago

Deep dive on pay packages; Lilly strikes $3.2B buyout; Pfizer’s R&D head to depart; and more

10 months ago

Lilly says lupus drug dropped from pipeline failed to show efficacy

10 months ago

First page Previous page 131 132 133134135 136 137 Next page Last page